COVID-19: Trump threatens ‘Retaliation’ hydroxychloroquine tablets withheld

US President Donald Trump hints that there if India doesn’t allow export of anti-malarial Hydroxychloroquine tablets used to fight corona infection to the US, there may be retaliation.

  • India is one of the largest manufacturers of Hydroxychloroquine tablets in the world, banned its export along with other medicines in March to combat the Corona infection. 
  • In a news conference, Trump said last week he requested help from PM Narendra Modi to release the sale of Hydroxychloroquine tablets to treat the growing number of coronavirus patients but shocked to see that Mr. Modi didn’t comply.

He also brought the US long-running grievances with India on trade issues into the light. A joint step taken by the two countries to bridge the gap between them in times of emergencies got failed in February, Trump’s first visit to India.

The US government placed the order for Hydroxychloroquine tablets in March through an agency taking care of medical supplies and equipment needed to deal with the corona pandemic. 

The White House has declared Hydroxychloroquine tablets as an effective medicine in the treatment for COVID-19. However, the health experts of the US have officially approved the medication only for treating malaria, rheumatoid arthritis, and lupus. 

The Food and Drug Administration of the US also warned the citizens against the use of Hydroxychloroquine tablets as a potential medicine for COVID-19. It recommended wearing a cloth face-covering in public and should be washed regularly. Wash hands and face immediately after removing the covering.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.